• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯合子和杂合子完全性葡萄胎的恶性潜能。

Malignant potential of homozygous and heterozygous complete moles.

作者信息

Wake N, Seki T, Fujita H, Okubo H, Sakai K, Okuyama K, Hayashi H, Shiina Y, Sato H, Kuroda M

出版信息

Cancer Res. 1984 Mar;44(3):1226-30.

PMID:6318983
Abstract

There are two main mechanisms of origin for complete hydatidiform mole: (a) fertilization of an empty egg by a haploid sperm followed by duplication (monospermic mole); and (b) fertilization of such an egg by two haploid spermatozoa (dispermic mole). The former is inevitably homozygous (homozygous mole), whereas the latter may be heterozygous for a given genetic marker (heterozygous mole). A recent cytogenetic study showed that three cases of choriocarcinoma were undoubtedly heterozygous, which prompted us to compare the incidence of postmolar sequelae between patients with homozygous moles and those with heterozygous moles. Making use of chromosomal heteromorphisms and human lymphocyte antigen and phosphoglucuromutase 1 polymorphisms, we established the androgenetic origin of a complete mole in 49 of 56 cases. Homozygosity was confirmed in 21 moles, and heterozygosity was confirmed in five. Three of five patients with heterozygous moles developed postmolar trophoblastic disease, whereas none of the 21 patients with homozygous moles suffered postmolar trophoblastic disease except one who showed signs of degenerating residual trophoblasts. Consistent with this observation is the fact that all of the four destructive moles studied here were of dispermic origin. Thus, heterozygous moles seem to have a higher malignant potential than do homozygous moles.

摘要

完全性葡萄胎主要有两种起源机制

(a)单倍体精子使空卵受精,随后发生复制(单精子性葡萄胎);(b)两个单倍体精子使此类卵子受精(双精子性葡萄胎)。前者必然是纯合子(纯合子葡萄胎),而后者对于特定遗传标记可能是杂合子(杂合子葡萄胎)。最近一项细胞遗传学研究表明,三例绒毛膜癌无疑是杂合子,这促使我们比较纯合子葡萄胎患者和杂合子葡萄胎患者葡萄胎后后遗症的发生率。利用染色体异态性、人类淋巴细胞抗原和磷酸葡萄糖醛酸变位酶1多态性,我们确定了56例中的49例完全性葡萄胎的父系起源。在21例葡萄胎中证实为纯合子,5例证实为杂合子。5例杂合子葡萄胎患者中有3例发生了葡萄胎后滋养细胞疾病,而21例纯合子葡萄胎患者中除1例显示有退化的残留滋养细胞迹象外,均未患葡萄胎后滋养细胞疾病。与此观察结果一致的是,此处研究的所有4例侵蚀性葡萄胎均为双精子起源。因此,杂合子葡萄胎似乎比纯合子葡萄胎具有更高的恶性潜能。

相似文献

1
Malignant potential of homozygous and heterozygous complete moles.纯合子和杂合子完全性葡萄胎的恶性潜能。
Cancer Res. 1984 Mar;44(3):1226-30.
2
[The propensity to malignancy of dispermic, heterozygous moles].[双精子、杂合性葡萄胎的恶性倾向]
Hokkaido Igaku Zasshi. 1987 Jul;62(4):564-72.
3
The propensity to malignancy of dispermic heterozygous moles.双精子杂合性葡萄胎的恶性倾向。
Placenta. 1987 May-Jun;8(3):319-26. doi: 10.1016/0143-4004(87)90056-7.
4
[The propensity to malignant changes in heterozygous moles].[杂合性痣发生恶性变化的倾向]
Nihon Sanka Fujinka Gakkai Zasshi. 1982 Dec;34(12):2221-8.
5
The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.杂合性完全性葡萄胎的滋养细胞肿瘤风险高于纯合性完全性葡萄胎。
Hum Reprod. 2010 May;25(5):1183-91. doi: 10.1093/humrep/deq052. Epub 2010 Mar 5.
6
[A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].[关于滋养层细胞瘤发生的研究,兼论其孤雄生殖起源]
Hokkaido Igaku Zasshi. 1984 Jan;59(1):21-7.
7
Chromosome and cellular origin of choriocarcinoma.绒毛膜癌的染色体及细胞起源
Cancer Res. 1981 Aug;41(8):3137-43.
8
[Genetic studies of hydatidiform mole with 46,XY karyotype (author's transl)].46,XY核型葡萄胎的遗传学研究(作者译)
Nihon Sanka Fujinka Gakkai Zasshi. 1981 Oct;33(10):1664-8.
9
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.杂合性/异二倍体完全性葡萄胎会显著增加葡萄胎后妊娠滋养细胞疾病的风险。
Mod Pathol. 2020 Oct;33(10):1979-1988. doi: 10.1038/s41379-020-0566-4. Epub 2020 May 13.
10
Cytogenetic and clinicopathologic studies of partial moles.部分性葡萄胎的细胞遗传学和临床病理研究
Obstet Gynecol. 1986 Aug;68(2):259-62.

引用本文的文献

1
Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.妊娠滋养细胞疾病的基因分型诊断:精准医学的前沿。
Mod Pathol. 2021 Sep;34(9):1658-1672. doi: 10.1038/s41379-021-00831-9. Epub 2021 Jun 4.
2
MiR-30a-5p inhibits proliferation and metastasis of hydatidiform mole by regulating B3GNT5 through ERK/AKT pathways.miR-30a-5p 通过调控 B3GNT5 通路抑制 ERK/AKT 信号通路抑制葡萄胎的增殖和转移。
J Cell Mol Med. 2020 Aug;24(15):8350-8362. doi: 10.1111/jcmm.15247. Epub 2020 Jun 23.
3
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
杂合性/异二倍体完全性葡萄胎会显著增加葡萄胎后妊娠滋养细胞疾病的风险。
Mod Pathol. 2020 Oct;33(10):1979-1988. doi: 10.1038/s41379-020-0566-4. Epub 2020 May 13.
4
Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.204例散发性葡萄胎的综合分析:重新审视危险因素及其与葡萄胎基因型的相关性。
Mod Pathol. 2020 May;33(5):880-892. doi: 10.1038/s41379-019-0432-4. Epub 2019 Dec 19.
5
Genome-wide single nucleotide polymorphism array analysis unveils the origin of heterozygous androgenetic complete moles.全基因组单核苷酸多态性微阵列分析揭示了杂合性完全性雄激素性葡萄胎的起源。
Sci Rep. 2019 Aug 29;9(1):12542. doi: 10.1038/s41598-019-49047-7.
6
Establishment and characterization of cell lines derived from complete hydatidiform mole.完全性葡萄胎来源细胞系的建立与鉴定
Int J Mol Med. 2017 Sep;40(3):614-622. doi: 10.3892/ijmm.2017.3067. Epub 2017 Jul 14.
7
Variable Number Tandem Repeat (VNTR) Genotyping of Hydatidiform Mole in Iranian Patients.伊朗患者葡萄胎的可变数目串联重复序列(VNTR)基因分型
Avicenna J Med Biotechnol. 2014 Oct;6(4):246-53.
8
Clinicopathologic profile of gestational trophoblastic disease.妊娠滋养细胞疾病的临床病理特征
Wien Klin Wochenschr. 2003 Jan 31;115(1-2):29-35. doi: 10.1007/BF03040269.
9
Origin of teratomas and twins.畸胎瘤与双胞胎的起源。
Hum Genet. 1986 Nov;74(3):215-8. doi: 10.1007/BF00282536.
10
Diagnosis of molar pregnancy and persistent trophoblastic disease by flow cytometry.通过流式细胞术诊断葡萄胎和持续性滋养细胞疾病。
J Clin Pathol. 1987 Jun;40(6):615-20. doi: 10.1136/jcp.40.6.615.